Drug Price Forecast Projects 4.57% Increase in 2020 Hospital Drug Spending
Vizient, Inc. announced the release of its July 2019 Drug Price Forecast. The forecast projects that health systems-including inpatient and non-acute environments-can expect a 4.57% increase for pharmaceutical purchases made from Jan. 1, 2020 to Dec. 31, 2020. The forecast also includes projections for specialty pharmacy and pediatric-specific medications.
Highlights from the forecast report include:
- Specialty drug price inflation is predicted to be 4.23%
- The composition of the U.S. biosimilars market could change dramatically in the very near future
- Drug shortages compromise patient care and contribute to higher costs, both direct and indirect
- Providers treating leukemia patients will experience higher costs as the standard of care shifts to new therapy combinations
- Supply challenges in the Immune globulin intravenous (IgIV) market will continue and prices are expected to steadily rise
The forecast can be accessed here.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
